Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SLN anticorps

SLN Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7118792
  • Antigène Voir toutes SLN Anticorps
    SLN (Sarcolipin (SLN))
    Reactivité
    Humain, Souris, Rat
    Hôte
    • 2
    • 1
    Lapin
    Clonalité
    • 2
    • 1
    Polyclonal
    Conjugué
    • 3
    Cet anticorp SLN est non-conjugé
    Application
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
    Purification
    Immunogen affinity purified
    Pureté
    ≥95 % as determined by SDS-PAGE
    Immunogène
    sarcolipin
    Isotype
    IgG
    Top Product
    Discover our top product SLN Anticorps primaire
  • Indications d'application
    WB: 1:500-1:1000, IHC: 1:50-1:500, IF: 1:20-1:200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
    Date de péremption
    12 months
  • Antigène
    SLN (Sarcolipin (SLN))
    Autre désignation
    SLN (SLN Produits)
    Synonymes
    anticorps 2310045A07Rik, anticorps sarcolipin, anticorps Sln, anticorps SLN
    Sujet
    Synonyms:sarcolipin, SLN Background:Reversibly inhibits the activity of ATP2A1 in sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in muscle. Required for muscle-based, non-shivering thermogenesis(By similarity).
    Poids moléculaire
    4 kDa
    ID gène
    6588
    UniProt
    O00631
    Pathways
    Negative Regulation of Transporter Activity
Vous êtes ici: